CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.45
+1.00 (2.67%)
Sep 4, 2025, 1:39 PM CST
2.67%
Market Cap8.30B
Revenue (ttm)3.21M
Net Income (ttm)-230.38M
Shares Out214.01M
EPS (ttm)-1.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume218,443
Average Volume318,511
Open38.00
Previous Close37.45
Day's Range37.00 - 38.95
52-Week Range35.75 - 68.80
Beta-0.51
RSI50.40
Earnings DateAug 7, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.